Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis

Please use this identifier to cite or link to this item: http://scholars.ntou.edu.tw/handle/123456789/1287

Title:	Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis
Authors:	Chu, M. P. Brody, J. Kohrt, H. E. Frank, M. J. Khodadoust, M. Reddy, S. Advani, R. H. Gupta, N. K. Laport, G. Maeda, L. S. Meyer, E. Miklos, D. B. Negrin, R. Rezvani, A. R. Wen-Kai Weng Sheehan, K. Faham, M. Czerwinski, D. K. Okada, A. Levy, R.
Issue Date:	Dec-2015
Journal Volume:	126
Journal Issue:	23
Source:	Blood
URI:	http://scholars.ntou.edu.tw/handle/123456789/1287
ISSN:	0006-4971
DOI:	://WOS:000368019005014
Appears in Collections:	河海工程學系

Show full item record

Last Week
0

Last month
0

checked on Oct 13, 2022

Check

DSpace CRIS